Inventor
JOHN MASCOLA
Inventor
US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
C07KPeptides24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C12NMicroorganisms or enzymes19%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
B82YSpecific uses or applications of nanostructures1%
C12YEnzymes1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
12,545,719Neutralizing antibodies to GP120 and their use202612,458,691HIV-1 ENV fusion peptide immunogens and their use202512,435,113Prefusion PIV F immunogens and their use202512,275,758Prefusion RSV F proteins and their use202512,202,886Neutralizing antibodies to GP120 and their use202512,172,038Anti-coronavirus antibodies and methods of use202412,145,968Recombinant HIV-1 envelope proteins and their use202412,053,519HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use202412,043,66010E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use202411,939,356Self-assembling insect ferritin nanoparticles202411,890,339Nipah virus immunogens and their use202411,878,998Prefusion RSV F proteins and their use202411,845,778Prefusion PIV F immunogens and their use202311,780,885Zika viral antigen constructs202311,760,790Neutralizing antibodies to HIV-1 Env and their use202311,602,559HIV-1 Env fusion peptide immunogens and their use202311,459,360Recombinant HIV-1 envelope proteins and their use202211,447,541Anti-coronavirus antibodies and methods of use202211,370,828Anti-coronavirus antibodies and methods of use202211,236,152Neutralizing antibodies to HIV-1 GP41 and their use202211,174,292Substitutions-modified prefusion RSV F proteins and their use202111,136,356Recombinant HIV-1 envelope proteins and their use2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to US HEALTH (19)· patent assignee history
2021–2026Based in US· patent location history
2022–2024Patents assigned to THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SVCS (3)· patent assignee history
2022Patents assigned to ABCELLERA BIOLOGIES INC (2)· patent assignee history
2022–2024Patents assigned to UNIV COLUMBIA (2)· patent assignee history
2023–2025Patents assigned to INST RES BIOMEDICINE (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| US HEALTH | 19 | 2021–2026 |
| THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SVCS | 3 | 2022–2024 |
| ABCELLERA BIOLOGIES INC | 2 | 2022 |
| INST RES BIOMEDICINE | 2 | 2023–2025 |
| UNIV COLUMBIA | 2 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 22 | 2021–2026 |